Search results

Selected filters:

Litigation
North America

Article type

Topic

Sector

Jurisdictions

869 results found for your search

Sort options
15 February 2019

AbbVie’s Humira strategy to be scrutinised in first evergreening unclean hands challenge

In a Delaware case Boehringer Ingelheim accuses the Illinois company of improper conduct in deliberately constructing a patent thicket to protect against generic versions of its blockbuster drug.

14 February 2019

As 101 debate continues, Iancu offers clear message to Federal Circuit

With new guidelines set to reshape patent examination, the USPTO head makes the case for revisiting subject matter precedent

14 February 2019

World’s most valuable startup buys patents again

The company behind Tik Tok bought out much of a struggling smartphone maker’s patent portfolio in January. USPTO assignments from last week show what assets Beijing-based ByteDance came away with

13 February 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco 

11 February 2019

RPX strikes deal to acquire remaining patent portfolio of Creative subsidiary

The settlement deal ends litigation by the Singapore company’s ZiiLabs unit against Nvidia, and will net shareholders around $17.5 million

08 February 2019

The US’s first all biosimilar patent suit shows new pharma IP landscape is emerging

Coherus launched Delaware action against Amgen in what is likely to become an increasingly familiar life sciences litigation scenario.

08 February 2019

US patent system jumps to second in the world, though the biopharma sector may not agree

PTAB reforms help fuel a miraculous rise up the latest International IP Index, but a recent Federal Circuit decision on eligibility highlights the serious challenges that remain - especially for life sciences companies

07 February 2019

An entire “industry revolt” hinges on judge’s decision in FTC v Qualcomm

If the Commission and Apple are successful in rewriting the rules for chipmaker's licensing arm beware of unintended consequences that reduce choice and harm consumers, expert analyst states

05 February 2019

USPTO rules on patent term adjustment set to change following CAFC decision

The Federal Circuit’s precedential judgment in Supernus Pharmaceuticals v Iancu is good news for rights holders – especially those in life sciences

05 February 2019

TiVo might be about to split at a time when its licensing business has significant concerns

Latest report suggests that result of a strategic review will see the company's product and IP arms separate, but current courtroom tussle with Comcast means the timing is not great

04 February 2019

As 5th birthday nears LOTNet aims to prove you can monetise patents and be a member at the same time

After Microsoft's headline grabbing decision to sign-up to the network last year, LOT CEO “absolutely expects IBM to join” once its Red Hat acquisition is finalised

01 February 2019

We have not been informed of any Chinese antitrust investigation of us, Ericsson tells <em>IAM</em>

Swedish company issues statement after an unsourced Chinese media article claims that a probe into its licensing practices is underway

01 February 2019

Still no sign of a patent war as the world’s largest automakers see US litigation slump

Ford faces new confrontation over alleged infringement of MIT-owned IP, but number of suits against car giant well down from 2012-2014 peak

31 January 2019

The pharma fightback

Brand name pharmaceutical companies are facing a policy-making onslaught; with their IP strategies firmly in the spotlight, many are being forced to speak up for the rights that underpin their products.

31 January 2019

Excalibur IP accuses Spotify of infringing former Yahoo! patents

Delaware lawsuit is first move to litigate assets since former RPX dealmaker took control of portfolio